Synonyms:
Status: Phase 1
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: HP4L6MXF10

Structure

InChI Key MGGBYMDAPCCKCT-UHFFFAOYSA-N
Smile COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1
InChI
InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34)

Physicochemical Descriptors

Property Name Value
Molecular Formula C29H40N8O3S
Molecular Weight 580.76
AlogP 3.77
Hydrogen Bond Acceptor 11.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 9.0
Polar Surface Area 115.82
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 41.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR ALK tyrosine kinase receptor inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Follicular 1 D008224 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEBI 167650
ChEMBL CHEMBL3545360
DrugBank DB12729
EPA CompTox DTXSID90149038
FDA SRS HP4L6MXF10
Guide to Pharmacology 7740
PDB F6O
PubChem 25134326
SureChEMBL SCHEMBL2827739
ZINC ZINC000068120928